François-Xavier Nouhaud1, Jean-Christophe Bernhard2, Pierre Bigot3, Zine-Eddine Khene4, François Audenet5, Herve Lang6, Sebastien Bergerat6, Guillaume Fraisse5, Nicolas Grenier7, François Cornelis7, Cosmina Nedelcu8, Sofiane Béjar9, Gaëlle Fromont-Hankard10, Yves Allory11, Véronique Lindner12, Virginie Verkarre13, Laurent Daniel14, Mokrane Yacoub15, Jean-Michel Correas16, Arnaud Méjean5, Nathalie Rioux-Leclercq17, Karim Bensalah4. 1. Department of Urology, Rouen University Hospital, 1 rue de Germont, 76000, Rouen, France. fx_nouhaud@hotmail.fr. 2. Department of Urology, Bordeaux University Hospital, Bordeaux, France. 3. Department of Urology, Angers University Hospital, Angers, France. 4. Department of Urology, Rennes University Hospital, Rennes, France. 5. Department of Urology, European Georges Pompidou Hospital, APHP, Paris, France. 6. Department of Urology, Strasbourg University Hospital, Strasbourg, France. 7. Department of Radiology, Bordeaux University Hospital, Bordeaux, France. 8. Department of Radiology, Angers Urology Hospital, Angers, France. 9. Department of Radiology, Rouen University Hospital, Rouen, France. 10. Department of Pathology, Tours University Hospital, Tours, France. 11. Department of Pathology, Henry Mondor University Hospital, APHP, Créteil, France. 12. Department of Pathology, Strasbourg University Hospital, Strasbourg, France. 13. Department of Pathology, European Georges Pompidou Hospital, APHP, Paris, France. 14. Department of Pathology, Timone University Hospital, APHM, Marseille, France. 15. Department of Pathology, Bordeaux University Hospital, Bordeaux, France. 16. Department of Radiology, European Georges Pompidou Hospital, APHP, Paris, France. 17. Department of Pathology, Rennes University Hospital, Rennes, France.
Abstract
PURPOSE: To evaluate and compare pathological characteristics of renal cysts Bosniak IIF, III and IV in light of recent histological classification. PATIENTS AND METHODS: The French research network for kidney cancer UroCCR conducted a multicentre study on patients treated surgically for a renal cyst between 2007 and 2016. Independent radiological and centralized pathological reviews were performed for every patient. Pathological characteristics were compared to the Bosniak classification. RESULTS: Of a total 216 patients included, 175 (81.0%) tumours (90.9% of Bosniak IV, 69.8% of Bosniak III) were malignant or had a low malignant potential, with 60% of clear cell renal cell carcinoma (CCRCC), 24% of papillary RCC (PRCC) and 6.9% of multilocular cystic renal tumour of low malignant potential (MCRTLMP). Malignancies were mostly of low pT stage (86.4% of pT1-2), and low ISUP grade (68.0% of 1-2). Bosniak III cysts had a lower rate of CCRCC (46.7 vs. 67.3%), higher rate of PRCC (30 vs. 20.9%) and MCRTLMP (18.3 vs. 0.9%) compared to Bosniak IV (p < 0.001). Low-malignant potential lesions were less likely Bosniak IV and pT3-4 stage was more frequent in Bosniak IV vs. III (15.7 vs. 3.5%; p = 0.04). There were two recurrences (1.1%) and no cancer-related death occurred during follow-up. CONCLUSION: These results confirmed that cystic renal malignancies have excellent prognosis. Bosniak III cysts had a low malignant potential, which suggests surveillance could be an option for these lesions.
PURPOSE: To evaluate and compare pathological characteristics of renal cysts Bosniak IIF, III and IV in light of recent histological classification. PATIENTS AND METHODS: The French research network for kidney cancer UroCCR conducted a multicentre study on patients treated surgically for a renal cyst between 2007 and 2016. Independent radiological and centralized pathological reviews were performed for every patient. Pathological characteristics were compared to the Bosniak classification. RESULTS: Of a total 216 patients included, 175 (81.0%) tumours (90.9% of Bosniak IV, 69.8% of Bosniak III) were malignant or had a low malignant potential, with 60% of clear cell renal cell carcinoma (CCRCC), 24% of papillary RCC (PRCC) and 6.9% of multilocular cystic renal tumour of low malignant potential (MCRTLMP). Malignancies were mostly of low pT stage (86.4% of pT1-2), and low ISUP grade (68.0% of 1-2). Bosniak III cysts had a lower rate of CCRCC (46.7 vs. 67.3%), higher rate of PRCC (30 vs. 20.9%) and MCRTLMP (18.3 vs. 0.9%) compared to Bosniak IV (p < 0.001). Low-malignant potential lesions were less likely Bosniak IV and pT3-4 stage was more frequent in Bosniak IV vs. III (15.7 vs. 3.5%; p = 0.04). There were two recurrences (1.1%) and no cancer-related death occurred during follow-up. CONCLUSION: These results confirmed that cystic renal malignancies have excellent prognosis. Bosniak III cysts had a low malignant potential, which suggests surveillance could be an option for these lesions.
Authors: Thu Tran; Carol L Jones; Sean R Williamson; John N Eble; David J Grignon; Shaobo Zhang; Mingsheng Wang; Lee Ann Baldridge; Lisha Wang; Rodolfo Montironi; Marina Scarpelli; Puay-Hoon Tan; Novae B Simper; Eva Comperat; Liang Cheng Journal: Histopathology Date: 2015-10-21 Impact factor: 5.087
Authors: Bradley C Leibovich; Christine M Lohse; Paul L Crispen; Stephen A Boorjian; R Houston Thompson; Michael L Blute; John C Cheville Journal: J Urol Date: 2010-02-19 Impact factor: 7.450
Authors: Adam C Reese; Pamela T Johnson; Michael A Gorin; Phillip M Pierorazio; Mohamad E Allaf; Elliot K Fishman; George J Netto; Christian P Pavlovich Journal: Urol Oncol Date: 2014-07-09 Impact factor: 3.498
Authors: K Bensalah; L Albiges; J-C Bernhard; P Bigot; T Bodin; R Boissier; J-M Corréas; P Gimel; J-A Long; F-X Nouhaud; I Ouzaïd; P Paparel; N Rioux-Leclercq; A Méjean Journal: Prog Urol Date: 2016-11 Impact factor: 0.915
Authors: Borje Ljungberg; Karim Bensalah; Steven Canfield; Saeed Dabestani; Fabian Hofmann; Milan Hora; Markus A Kuczyk; Thomas Lam; Lorenzo Marconi; Axel S Merseburger; Peter Mulders; Thomas Powles; Michael Staehler; Alessandro Volpe; Axel Bex Journal: Eur Urol Date: 2015-01-21 Impact factor: 20.096
Authors: Patrick E Teloken; R Houston Thompson; Satish K Tickoo; Angel Cronin; Caroline Savage; Victor E Reuter; Paul Russo Journal: J Urol Date: 2009-09-16 Impact factor: 7.450
Authors: Stephen D W Beck; Manish I Patel; Mark E Snyder; Michael W Kattan; Robert J Motzer; Victor E Reuter; Paul Russo Journal: Ann Surg Oncol Date: 2004-01 Impact factor: 5.344
Authors: Kun Shan; A Bu DU Li Ai Ze Zi Ha Li Fu; Ningning Liu; Qiliang Cai; Qingfeng Fu; Leyi Liu; Xiaoyu Sun; Zhihong Zhang Journal: Medicine (Baltimore) Date: 2020-11-13 Impact factor: 1.889
Authors: A Méjean; M Rouprêt; F Rozet; K Bensalah; T Murez; X Game; X Rebillard; R Mallet; A Faix; P Mongiat-Artus; G Fournier; Y Neuzillet Journal: Prog Urol Date: 2020-03-30 Impact factor: 0.915